Pyrazines

Results: 158



#Item
131January 16, 2014 Press Release Mitsubishi Tanabe Pharma Corporation TELAVIC 250 mg Tablets, Antiviral Application for Additional Indication for Chronic Hepatitis C Genotype 2

January 16, 2014 Press Release Mitsubishi Tanabe Pharma Corporation TELAVIC 250 mg Tablets, Antiviral Application for Additional Indication for Chronic Hepatitis C Genotype 2

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2014-01-16 02:49:49
132AIDS InfoNet  www.aidsinfonet.org Fact Sheet Number 676

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 676

Add to Reading List

Source URL: aidsinfonet.org

Language: English - Date: 2014-03-17 13:28:58
133HIGHLIGHTS OF PRESCRIBING INFORMATION   These highlights do not include all the information needed to use CHANTIX safely and effectively. See full prescribing information for CHANTIX.

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CHANTIX safely and effectively. See full prescribing information for CHANTIX.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-07-22 16:47:12
134Kentucky Department for Medicaid Services

Kentucky Department for Medicaid Services

Add to Reading List

Source URL: chfs.ky.gov

Language: English - Date: 2014-08-21 09:49:51
135Kentucky Department for Medicaid Services

Kentucky Department for Medicaid Services

Add to Reading List

Source URL: chfs.ky.gov

Language: English - Date: 2014-08-21 09:33:00
136The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

Add to Reading List

Source URL: www.fda.gov

Language: English
137• Hypotension can occur. Caution should be used when treating patients receiving antihypertensives, those with a history of syncope, and those who are dehydrated. (5.3) • Patients with risk factors for, or existing h

• Hypotension can occur. Caution should be used when treating patients receiving antihypertensives, those with a history of syncope, and those who are dehydrated. (5.3) • Patients with risk factors for, or existing h

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:10:04
138CDER New Molecular Entity (NME) and New Biologic Approvals Calendar Year 2011

CDER New Molecular Entity (NME) and New Biologic Approvals Calendar Year 2011

Add to Reading List

Source URL: www.fda.gov

Language: English
139Resistance in the Era of HCV Protease Inhibitors Antiviral drug resistance and the battle for a cure below the limit of detection  Ann Kwong, PhD

Resistance in the Era of HCV Protease Inhibitors Antiviral drug resistance and the battle for a cure below the limit of detection Ann Kwong, PhD

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2012-02-15 09:31:05
140Incivek (telaprevir) tablets label

Incivek (telaprevir) tablets label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-10-29 08:39:33